Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
andreessen-horowitz
antibiotics
axial spondyloarthritis
bausch health
big data
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
business
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cloud
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
What
biopharmaceutical
2
×
drug
2
×
new
alto
andreessen
approval
artificial
bio
biogen’s
braintree
bryan
capital
companies
convo
develop
discovery
earlier
early
failures
firm
founded
founder
fund
funding
grow
horowitz
identify
intelligence
johnson’s
led
littered
medicines
million
nash
news
palo
participation
platform
price
raised
Language
Current search:
biopharmaceutical
×
drug
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@venturebeat.com
6 years ago
TwoXar raises $10 million from SoftBank, Andreessen Horowitz, and OS Fund to grow its AI drug discovery platform